Abstract
Acid-base disorders, unless severe, usually pose little risk for patients and do not require urgent intervention. In mild cases, the physician should be less concerned about therapy than about why the disorder is present, since even minor acid-base disturbances can provide clues to the presence of serious underlying disease. On the other hand, when severe, an abnormal blood pH may itself threaten vital bodily functions and therefore demands prompt therapy aimed at correcting the acid-base imbalance. This chapter will discuss the management of these more severe disturbances. As will become apparent, the data used to support treatment recommendations are incomplete. Therefore, our recommendations in many cases will be based on clinical experience, rather than on clear evidence of improved outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Orringer CE, Eustace JC, Wunsch CD, Gardner LB. Natural history of lactic acidosis after grand-mal seizures: a model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med 1977; 297: 796–9.
Madias NE. Lactic acidosis. Kidney Int 1986; 29: 752–74.
Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med 1992; 20: 80–93.
Stacpoole PW, Wright EC, Baumgartner TG, et al. Natural history and course of acquired lactic acidosis in adults. Am J Med 1994; 97: 47–54.
Halperin ML, Cheema-Dhadli S, Halperin FA, Kamel KS. Rationale for the use of sodium bicarbonate in a patient with lactic acidosis due to a poor cardiac output. Nephron 1994; 66: 258–61.
Hindman BJ. Sodium bicarbonate in the treatment of subtypes of acute lactic acidosis: physiologic considerations. Anesthesiology 1990; 72: 1064–76.
Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med 1987; 106: 615–8.
Adrogue HJ, Tannen RL. Ketoacidosis, hyperosmolar states, and lactic acidosis. In: Kokko JP, Tannen RL (eds). Fluids and electrolytes. Philadelphia: W.B. Saunders, 1996: 643–74.
Ostrea EM, Odell GB. The influence of bicarbonate administration on blood pH in a “closed system”: clinical implications. J Pediatrics 1972; 80: 671–80.
Bushinsky DA, Coe FL, Katzenberg C, Szidon JP, Parks JH. Arterial Pco2 in chronic metabolic acidosis. Kidney Int 1982; 22: 311–4.
Arieff AI. Indications for use of bicarbonate in patients with metabolic acidosis. Br J Anaesthesia 1991; 67: 165–77.
Ayus JC, Krothapalli RK. Effect of bicarbonate administration on cardiac function. Am J Med 1989; 87: 5–6.
Cooper DJ, Worthley LIG. Adverse haemodynamic effects of sodium bicarbonate in metabolic acidosis. Intensive Care Med 1987; 13: 425–7.
Delany S, Stokes J. Bicarbonate administration in acidaemia -is it therapeutic? N Z Med J 1992; 105: 6–7.
Gabow PA. Sodium bicarbonate: a cure or curse for metabolic acidosis? J Crit Illness 1989; 4: 13–28.
Gambassi G, Carbonin P. Bicarbonate is of no value. BMJ 1993; 307: 627.
Graf H, Arieff AI. The use of sodium bicarbonate in the therapy of organic acidosis. Intensive Care Med 1986; 12: 285–8.
Stacpoole PW. Lactic acidosis: the case against bicarbonate therapy. Ann Intern Med 1986; 105: 276–8.
Young GP. Reservations and recommendations regarding sodium bicarbonate administration in cardiac arrest. J Emerg Med 1988; 6: 321–3.
Weisfeldt ML, Guerci AD. Sodium bicarbonate in CPR. JAMA 1991; 266: 2129–30.
Graf H, Leach W, Arieff AI. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science 1985; 227: 754–6.
Bishop RL, Weisfeldt ML. Sodium bicarbonate administration during cardiac arrest: effect on arterial pH, pCO2 and osmolality. JAMA 1976; 235: 506–9.
Ritter JM, Doktor HS, Benjamin N. Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 1990; 335: 1243–6.
Bersin RM, Arieff AI. Improved hemodynamic function during hypoxia with carbicarb, a new agent for the management of acidosis. Circulation 1988; 77: 227–33.
Kette F, Weil MH, von Planta M, Gazmuri RJ, Rackow EC. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation 1990; 81: 1660–6.
Kette F, Weil MH, Gazmuri RJ. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure. JAMA 1991; 266: 2121–6.
Rhee KH, Toro LO, McDonald GG, Nunnally RL, Levin DL. Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis. Chest 1993; 104: 913–8.
Levraut J, Labib Y, Chave S, Payan P, Raucoules-Aime M, Grimaud D. Effect of sodium bicarbonate on intracellular pH under different buffering conditions. Kidney Int 1996; 49: 1262–7.
Mattar JA, Weil MH, Shubin H, Stein L. Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. Am J Med 1974; 56: 162–8.
Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 1990; 112: 492–8.
Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 1991; 19: 1352–6.
Bersin RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med 1989; 87: 7–14.
Kaehny WD. Anderson RJ. Bicarbonate therapy of metabolic acidosis. Crit Care Med 1994; 22: 1525–7.
Garella S, Dana CL, Chazan JA. Severity of metabolic acidosis as a determinant of bicarbonate requirements. N Engl J Med 1973; 289: 121–6.
Huseby JS, Gumprecht DG. Hemodynamic effects of rapid bolus hypertonic sodium bicarbonate. Chest 1981; 79: 552–4.
Adrogue HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing acid-base status in circulatory failure: differences between arterial and central venous blood. N Engl J Med 1989; 320: 1312–6.
Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med 1986; 315: 153–6.
Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, III: adult advanced cardiac life support. JAMA 1992; 268: 2199–241.
von Planta M, Bar-Joseph G, Wiklund L, Bircher NG, Falk JL, Abramson NS. Pathophysiologic and therapeutic implications of acid-base changes during CPR. Ann Emerg Med 1993: 22: 404–10.
Vukmir RB, Bircher NG, Radovsky A, Safar P. Sodium bicarbonate may improve outcome in dogs with brief or prolonged cardiac arrest. Crit Care Med 1995; 23: 515–22.
Filley GF, Kindig NB. Carbicarb, an alkalinizing ion-generating agent of possible clinical usefulness. Trans Am Clin Climatol Assoc 1984; 96: 141–53.
Shapiro JI, Elkins N, Logan J, Ferstenberg LB, Repine JE. Effects of sodium bicarbonate, disodium carbonate, and a sodium bicarbonate/carbonate mixture on the Pcoz of blood in a closed system. J Lab Clin Med 1995; 126: 65–9.
Blecic S, De Backer D, Deleuze M, Vachiery JL, Vincent JL. Correction of metabolic acidosis in experimental CPR: a comparative study of sodium bicarbonate, carbicarb, and dextrose. Ann Emerg Med 1991; 20: 235–8.
Leung JM, Landow L, Franks M, et al. Safety and efficacy of intravenous carbicarb in patients undergoing surgery: comparison with sodium bicarbonate in the treatment of mild metabolic acidosis. Crit Care Med 1994; 22: 1540–9.
Bleich HL, Schwartz WB. Tris buffer (THAM): an appraisal of its physiologic effects and clinical usefulness. N Engl J Med 1966; 274: 782–7
von Planta M, Gudipati C, Weil MH, Kraus LJ, Rackow EC. Effects of tromethamine and sodium bicarbonate buffers during cardiac resuscitation. J Clin Pharmacol 1988; 28: 594–9.
Stacpoole PW, Lorenz AC, Thomas RG, Harman EM. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 1988; 108: 58–63.
Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 1992; 327: 1564–9.
Lebovitz HE. Diabetic ketoacidosis. Lancet 1995; 345: 767–72.
Adrogue HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int 1984; 25: 591–8.
Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med 1983; 75: 263–8.
Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986; 105: 836–40.
Gamba G, Oseguera J, Castrejon M, Gomez-Perez FJ. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Rev Invest Clin 1991; 43: 234–8.
Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J 1984; 289: 1035–8.
Assal JP, Aoki TT, Manzano FM, Kozak GP. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes 1974; 23: 405–11.
Bureau MA, Begin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatrics 1980; 96: 968–73.
Adrogue HJ, Barrero J, Eknoyan G. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. JAMA 1989; 262: 2108–13.
Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983; 57: 177–80.
Agarwal R, Knochel JP. Fluid and electrolyte disorders associated with alcoholism and liver disease. In: Kokko JP, Tannen RL (eds). Fluids and electrolytes. Philadelphia: W.B. Saunders, 1996: 449–85.
Fulop M. Alcoholic ketoacidosis. Endocrinol Metab Clinics NA 1993; 22: 209–19.
Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med 1991; 91: 119–28.
Miller PD, Heinig RE, Waterhouse C. Treatment of alcoholic acidosis: the role of dextrose and phosphorus. Arch Intern Med 1978; 138: 67–72.
Harrington JT, Cohen JJ. Metabolic acidosis. In: Cohen JJ, Kassirer JP (eds). Acid-base. Boston: Little, Brown and Company, 1982: 121–225.
Toto RD, Alpern RJ. Metabolic acid-base disorders. In: Kokko JP, Tannen RL (eds). Fluids and electrolytes. Philadelphia: W.B. Saunders, 1996: 201–66.
Rose BD. Metabolic acidosis. In: Clinical Physiology of Acid-Base and Electrolyte Disorders. McGraw-Hill, Inc., 1994: 540–603.
Swerdlow DL, Ries AA. Cholera in the Americas: guidelines for the clinician. JAMA 1992; 267: 1495–9.
Wang F, Butler T, Rabbani GH, Jones PK. The acidosis of cholera: contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med 1986; 315: 1591–5.
England BK, Mitch WE. Acid-base, fluid, and electrolyte aspects of parenteral nutrition. In: Kokko JP, Tannen RL (eds). Fluids and electrolytes. Philadelphia: W.B. Saunders, 1996: 787–801.
Kushner RF. Total parenteral nutrition-associated metabolic acidosis. J Parenter Enter Nutr 1986; 10: 306–10.
Velez RJ, Myers B, Guber MS. Severe acute metabolic acidosis (acute beriberi): an avoidable complication of total parenteral nutrition. J Parenter Enteral Nutrition 1985; 9: 216–9.
Garella S, Lorch JA. Hemodialysis and hemoperfusion for poisoning. In: Henrich WL (ed). Principles and practice of dialysis. Baltimore: Williams and Wilkins, 1994: 375–92.
Wine H, Savitt D, Abuelo JG. Ethylene glycol intoxication. Semin Dial 1994; 7: 338–45.
Pappas SC, Silverman N. Treatment of methanol poisoning with ethanol and hemodialysis. Canadian Med Assoc J 1982; 126: 1391–4.
Palmisano J, Gruver C, Adams ND. Absence of anion gap metabolic acidosis in severe methanol poisoning: a case report and review of the literature. Am J Kidney Dis 1987; 9: 441–4.
Baud FJ, Galliot M, Astier A, et al. Treatment of ethylene glycol poisoning with intravenous 4methylpyrazole. N Engl J Med 1988; 319: 97–100.
Roberts JR, Hodges J. Clinical Procedures in emergency medicine. Philadelphia: WB Saunders 1985: 1073–4.
Anonymous: Guide to custom dialysis, Vol 3. Lakewwood, CO; REDY Co., Revision E, 1992: 43–8.
Brezis M, Brown RS. An unsuspected cause for metabolic acidosis in chronic renal failure: Sorbent system hemodialysis. Am J Kidney Dis 1985; 6: 425–7
Gabow PA, Anderson RI, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Int Med 1978; 138: 1481–4.
Richlie DG, Anderson RJ. Contemporary management of salicylate poisoning: When should hemodialysis and hemoperfusion be used? Semin Dial 1996; 9: 257–64.
Madias NE, Cohen JJ. Respiratory acidosis. In: Cohen JJ, Kassirer JP (eds). Acid-base. Boston: Little, Brown and Company, 1982: 307–48.
Slutsky AS. Mechanical ventilation. Chest 1993; 104: 1833–59.
Kilburn KH. Shock, seizures, and coma with alkalosis during mechanical ventilation. Ann Intern Med 1966; 65: 977–84.
Bidani A, Tzouanakis AE, Cardenas VJ, Zwischenberger JB. Permissive hypercapnia in acute respiratory failure. JAMA 1994; 272: 957–62.
Menitove SM, Goldring RM. Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med 1983; 74: 898–901.
Lakshminarayan S, Sahn SA, Petty TL. Bicarbonate therapy in severe acute respiratory acidosis. Scand J Resp Dis 1973; 54: 128–31.
Brackett NC Jr, Wingo CF, Muren O, Solano JT. Acid-base response to chronic hypercapnia in man. N Engl J Med 1969; 280: 124–30.
Sonett J, Pagani FD, Baker LS, et al. Correction of intramyocardial hypercarbic acidosis with sodium bicarbonate. Circ Shock 1994; 42: 163–73.
Wetterberg T, Sjoberg T, Steen S. Effects of buffering in hypercapnia and hypercapnic hypoxemia. Acta Anaesthesiol Scand 1993; 37: 343–9.
Bear R, Goldstein M, Phillipson E, Ho M, Hammeke M, Feldman R, et al. Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. CMAJ 1977; 117: 900–3.
Miller PD, Berns AS. Acute metabolic alkalosis perpetuating hypercarbia. A role for acetazolamide in chronic obstructive pulmonary disease. JAMA 1977; 238: 2400–1.
Harrington JT, Kassirer JP. Metabolic alkalosis. In: Cohen JJ, Kassirer JP (eds). Acid/Base. Boston, Little, Brown and Company, 1982: 227–306.
Jacobson HR. Chloride-responsive alkalosis. In: Seldin DW, Giebisch G (eds). The regulation of acid-base balance. New York, Raven Press 1989: 431–58.
Altmann P. Clinical manifestations of electrolyte and acid-base disorders. In: Arieff AI, DeFronzo RA (eds). Fluid, electrolyte, and acid-base disorders. New York, Churchill Livingston Inc., 1995: 527–72.
Lubasch GB, Cohen BD, Young CW, Siverman GM, Rubin AL. Severe metabolic alkalosis with neurologic abnormalities. New Engl J Med 1958: 258; 1050–2.
Grace WJ, Barr DP. Complications of alkalosis. Am J Med 1948: 4; 331–7.
van Ypersele de Strihou C, Frans A. The respiratory response to chronic metabolic alkalosis and acidosis in disease. Clin Sci Mol Med 1973: 45: 439–48.
Javaheri S, Kazemi H. Metabolic alkalosis and hypo-ventilation in humans. Am Rev Resp Dis 1987: 136: 1011–6.
Garella S. Clinical acid/base disorders. In: Cameron S, Davison AM, Grunfeld JP, Kerr D, Ritz E (eds). Oxford Textbook of Clinical Nephrology. Oxford, New York, Tokyo, Oxford University Press, 1992: 917–65.
Wagner CW, Nesbit RR Jr, Mansberger AR Jr. Treat ment of metabolic alkalosis with intravenous hydrochloric acid. South Med J 1979; 72: 1241–5.
Rowlands BJ, Tindall SF, Elliott DJ. The use of hydrochloric acid and cimetidine to reverse severe metabolic alkalosis. Postgrad Med J 1978; 54: 123–6.
Knutsen OH. New method for administration of hydrochloric acid in metabolic alkalosis. Lancet 1983; i: 963–6.
Seldin DW, Welt LG, Cort JH. The role of sodium salts and adrenal steroids in the production of hypokalemic alkalosis. Yale J Biol Med 1956; 29: 229–47.
Bushinsky DA, Gennari FJ. Life-threatening hyperkalemia induced by arginine. Ann Int Med 1978; 89: 632–4.
Swartz RD, Jacobs F. Modified dialysis for metabolic alkalosis. Ann Int Med 1978; 88: 432–3.
Ayus JC, Olivero JJ, Adrogué HJ. Alkalemia associated with renal failure. Correction by hemodialysis with low-bicarbonate dialysate. Arch Int Med 1980; 140: 513–5.
Roberts M, Daugirdas JT. REDY sorbent hemodialysis. In: Handbook of dialysis. Daugirdas JT, Ing TS (eds). Boston/Toronto, Little, Brown and Company, 1988: 146–63.
Shapiro WB. REDY sorbent hemodialysis system. In: Dialysis Therapy, 2nd edition. Nissenson AR, Fine RN (eds). Philadelphia, Hanley and Belfus, 1992: 146–9.
Fraley DS, Adler S, Bruns F. Life-threatening metabolic alkalosis in a comatose patient. South Med J 1979; 72; 1024–5.
Grigor KC, Blair JJ, Hutchison JRS. The effect of acetazolamide on post-perfusion metabolic alkalosis. Br J Anesth 1971; 43: 352–61.
Schwartz WB, Brackett NC Jr, Cohen JJ. The response of extracellular hydrogen ion concentration to graded degrees of chronic hypercapnia: the physiologic limits of defense of pH. J Clin Invest 1965; 44: 291–301
Schwartz WB, Cohen II. The nature of the renal response to chronic disorders of acid-base equilibrium. Am J Med 1978; 64: 417–28.
Tannen RL, Hamid B. Adaptive changes in renal acidification in response to chronic respiratory acidosis. Am J Physiol 1985; 248: F492–9.
van Ypersele de Strihou C, Brasseur L, De Cononck J. The ‘carbon dioxide response curve’ for chronic hypercapnia in man. N Engl J Med 1966; 275: 117–22.
Kassirer JP, London AM, Goldman DM, Schwartz WB. On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med 1970; 49: 306–15.
Seldin DW, Welt LG, Cort JH. The role of sodium salts and adrenal steroids in the production of hypokalemic alkalosis. Yale J Biol Med 1956; 29: 229–47.
Hene RJ, Koomans HA, Dorhout Mees EJ, v.d. Stolpe A, Verhoef GE, Boer P. Correction of hypokalemia in Bartter’s syndrome by enalapril. Am J Kidney Dis 1987; 9: 200–5.
Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzo JL Jr, Radfar N, Taylor AA, Zusman RM, Bartter FC, Keiser HR. The kallikrein-kinin system in Bartter’s syndrome and its response to prostaglandin synthetase inhibition. J Clin Invest 1978; 61: 1671–82.
Garella S, Chazan JA, Cohen JJ. Saline-resistant metabolic alkalosis or `chloride-wasting nephropathy. ’ Ann Int Med 1970; 73: 31–8.
Baehler RW, Work J, Kotchen TA, McMorrow G, Guthrie G. Studies in the pathogenesis of Bartter’s syndrome. Am J Med 1980; 69: 933–88.
Lenfant C, Sullivan K. Adaptation to high altitude. N Engl J Med 1971; 284: 1298–309.
Lucius H, Galenbeck H, Kleine HO, Fabel H, Bartels H. Respiratory functions, buffer system and electrolyte concentrations of blood during human pregnancy. Respir Physiol 1970; 9: 311–7.
Ponten U. Consecutive acid-base changes in blood, brain tissue and cerebrospinal fluid during respiratory acidosis and baseosis. Acta Neurol Scand 1966; 42: 455–71.
Ayres SM, Grace WJ. Inappropriate ventilation and hypoxemia as causes of cardiac arrhythmias. The control of arrhythmias without antiarrhythmic drugs. Am Med 1969; 46: 495–505.
Magarian GJ. Hyperventilation syndromes: Infrequently recognized common expressions of anxiety and stress. Medicine 1982; 61: 219–36.
Wilson RF, Gibson D, Percinel AK, et al. Severe alkalosis in critically ill surgical patients. Arch Surg 1972; 105: 197–202.
Christensen MS. Acid-base changes in cerebrospinal fluid and blood and blood volume changes following prolonged hyperventilation in man. Br J Anaesth 1974; 46: 348–57.
Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. N Engl J Med 1998; 338: 26–34.
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Spital, A., Garella, S. (1998). Correction of acid-base derangements. In: Critical Care Nephrology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5482-6_27
Download citation
DOI: https://doi.org/10.1007/978-94-011-5482-6_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6306-7
Online ISBN: 978-94-011-5482-6
eBook Packages: Springer Book Archive